Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation16-11-2023
16-11-2023
Neutral Jyothy Laboratories; target of Rs 391: Motilal Oswal
Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 391 in its research report date November 07, 2023.10-11-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call held on Tuesday, November 7, 2023 for analyst/ investors to discuss the Un-audited Financial Results for the quarter and half year ended September 30, 2023 and the way forward.10-11-2023
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201508-11-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication-Unaudited financial result for the quarter and half year ended September 30, 202308-11-2023
Q2FY24 Quarterly & H1FY24 Bi-Annual Result Announced for Jyothy Labs Ltd.
Personal Products company Jyothy Labs announced Q2FY24 & H1FY24 results: 1. Financial Performance: Q2FY24: Net Sales at Rs 732 crore, up by 11.1% EBITDA margin at 18.5% (Rs 135.4 crore) versus 12.2% (Rs 80.4 crore), up by 68.3% Net Profit after Tax at Rs 104 crore from Rs 65.4 crore up by 59.1% H1FY24: Net Sales at Rs 1,419 crore, up by 13% EBITDA margin at 17.8% from 11.2% at Rs 252.8 crore, up by 80.2% Net Profit after Tax at Rs 200.2 crore, up by 77.1% Cash balance as of September 30, 2023, of Rs 440 Crore 2. Business Strategy and Execution: - Jyothy Labs focused on strengthening its core business through effective execution, resulting in higher growth. - The company leveraged its expanded distribution platform to mitigate the slowing consumption environment and drive sales in new geographies. - Market share growth was achieved across Jyothy Labs' portfolio, highlighting the success of increased brand investments, research & development efforts, and agile business operations. 3. Segment Performance: - Fabric Care: Sales of fabric care products, including fabric whitener, fabric enhancer, bar soap, detergent powder, and liquid detergent, increased by 10.6% in Q2FY24. The segment witnessed improvement in sales across all brands, with a focus on value offerings and premium liquid detergents. - Dishwashing: Sales of dishwashing products increased by 10% in Q2FY24. The growth was driven by the Exo and Pril brands, with onboarding new consumers and a focus on larger packs in the dishwashing liquid category. - Personal Care: Sales of personal care products, including body soap and toothpaste, showed a significant growth of 22.3% in Q2FY24. The Margo portfolio of Neem-based soaps, as well as the launch of Margo Neem Naturals with three new variants, contributed to this growth. - Household Insecticides: Sales of household insecticides increased by 3.4% in Q2FY24, with a consistent recovery after a challenging period. The company focused on innovation, brand affinity, and distribution in this segment, particularly with its liquid vaporizer portfolio. M R Jyothy, Managing Director, Jyothy Labs, stated, "The demand across our product portfolio has been stable. The inflationary environment has been a constant pressure on the consumption of FMCG products, however, given our business potential, we continue to expand our distribution footprint across India and further strengthen our brands which has resulted in consistent business growth. We are dedicated to delivering great value to all our consumers who have entrusted faith in us. With our continued and sustained focused efforts, we are confident to deliver committed results with every passing quarter and higher growth for all our stakeholders." Result PDF08-11-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) - Audio recording of Q2 FY24 Results Conference call07-11-2023
Jyothy Labs Results Earnings Call for Q2FY24
Conference Call with Jyothy Labs Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.07-11-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Investor Presentation07-11-2023
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on the un-audited financial results for the quarter and half year ended September 30, 202307-11-2023